[HTML][HTML] Long-chain n− 3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
BK Itariu, M Zeyda, EE Hochbrugger, A Neuhofer… - The American journal of …, 2012 - Elsevier
Background: Chronic adipose tissue inflammation is a hallmark of obesity, triggering the
development of associated pathologies, particularly type 2 diabetes. Long-chain n− 3 …
development of associated pathologies, particularly type 2 diabetes. Long-chain n− 3 …
Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.
BK Itariu, M Zeyda, EE Hochbrugger… - The American Journal …, 2012 - europepmc.org
Background Chronic adipose tissue inflammation is a hallmark of obesity, triggering the
development of associated pathologies, particularly type 2 diabetes. Long-chain n-3 PUFAs …
development of associated pathologies, particularly type 2 diabetes. Long-chain n-3 PUFAs …
Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
BK Itariu, M Zeyda, EE Hochbrugger, A Neuhofer… - 2012 - pubmed.ncbi.nlm.nih.gov
Background Chronic adipose tissue inflammation is a hallmark of obesity, triggering the
development of associated pathologies, particularly type 2 diabetes. Long-chain n-3 PUFAs …
development of associated pathologies, particularly type 2 diabetes. Long-chain n-3 PUFAs …
[HTML][HTML] Long-chain n− 3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial123
BK Itariu, M Zeyda, EE Hochbrugger… - The American Journal …, 2012 - ajcn.nutrition.org
Background: Chronic adipose tissue inflammation is a hallmark of obesity, triggering the
development of associated pathologies, particularly type 2 diabetes. Long-chain n− 3 …
development of associated pathologies, particularly type 2 diabetes. Long-chain n− 3 …
Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.
BK Itariu, M Zeyda, EE Hochbrugger, A Neuhofer… - 2012 - cabidigitallibrary.org
Background: Chronic adipose tissue inflammation is a hallmark of obesity, triggering the
development of associated pathologies, particularly type 2 diabetes. Long-chain n-3 PUFAs …
development of associated pathologies, particularly type 2 diabetes. Long-chain n-3 PUFAs …
[PDF][PDF] Long-chain n23 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
BK Itariu, M Zeyda, EE Hochbrugger, A Neuhofer… - Clin Nutr, 2012 - researchgate.net
Background: Chronic adipose tissue inflammation is a hallmark of obesity, triggering the
development of associated pathologies, particularly type 2 diabetes. Long-chain n23 PUFAs …
development of associated pathologies, particularly type 2 diabetes. Long-chain n23 PUFAs …
[引用][C] Long-chain n− 3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
BK Itariu, M Zeyda, EE Hochbrugger… - The American Journal …, 2012 - cir.nii.ac.jp
Long-chain n−3 PUFAs reduce adipose tissue and systemic inflammation in severely obese
nondiabetic patients: a randomized controlled trial | CiNii Research CiNii 国立情報学研究所 …
nondiabetic patients: a randomized controlled trial | CiNii Research CiNii 国立情報学研究所 …
[引用][C] Long-chain n―3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
BK ITARIU, M ZEYDA, M KREBS… - … American journal of …, 2012 - pascal-francis.inist.fr
Long-chain n―3 PUFAs reduce adipose tissue and systemic inflammation in severely
obese nondiabetic patients: a randomized controlled trial CNRS Inist Pascal-Francis CNRS …
obese nondiabetic patients: a randomized controlled trial CNRS Inist Pascal-Francis CNRS …